MedTrace Logo

Efficacy and Safety of Ivabradine to Reduce Heart Rate Prior to Coronary CT-angiography in Advanced Heart Failure: Comparison With β-Blocker

NCT03830957 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2019-04-12

No results posted yet for this study

Summary

The aim of this study is to compare the effects of Ivabradine and metoprolol to reduce heart rate prior to coronary CT angiography in patients with advanced heart failure.

Conditions

  • Heart Failure
  • CT Angiography
  • Ischemic Cardiomyopathy
  • Non-ischemic Cardiomyopathy
  • Heart Failure, Systolic
  • Heart Failure，Congestive
  • Heart Failure, Diastolic
  • Heart Rate Low

Interventions

DRUG

Ivabradine

7.5 mg oral single dose if the heart rate would not reach to 60/minute then give another dose, 7.5 mg

DRUG

Metoprolol

5 mg oral single dose if the heart rate would not reach to 60/minute then give another dose, 5 mg

Sponsors & Collaborators

  • Rajaie Cardiovascular Medical and Research Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-26
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Iran

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03830957 on ClinicalTrials.gov